口腔鳞状细胞癌患者淋巴结检出数、淋巴结比率与淋巴结转移数预后价值的比较
该研究纳入429例接受手术治疗的原发口腔鳞状细胞癌患者,用ROC曲线确定淋巴结检出数、淋巴结比率和淋巴结转移数的预后阈值分别为22、6.6%和3,log-rank检验显示淋巴结比率≤6.6%或淋巴结转移数≤3的患者总生存和无进展生存均显著改善(p<0.05),淋巴结检出数无预后意义,AIC分析提示淋巴结转移数是优于淋巴结检出数和淋巴结比率的预后指标,作者认为未来N分期应考虑纳入淋巴结转移数。
要点
- 淋巴结比率≤6.6%或淋巴结转移数≤3的患者总生存和无进展生存显著改善(p<0.05)。
- 淋巴结检出数在本研究中未显示预后意义。
- AIC分析提示淋巴结转移数的预后价值优于淋巴结检出数和淋巴结比率。
核心结论
- 将淋巴结比率或淋巴结转移数纳入TNM分类可能提高预后价值,如同其他类型癌症。
- 作者认为未来N分期应考虑纳入淋巴结转移数。
研究设计与样本
- 研究纳入接受手术治疗的原发口腔鳞状细胞癌患者429例。
- 采用受试者工作特征曲线确定最佳阈值,Kaplan-Meier曲线联合log-rank检验分析生存,计算Akaike信息准则比较模型拟合性能。
主要发现
- 预后阈值确定为淋巴结检出数22、淋巴结比率6.6%、淋巴结转移数3。
- 淋巴结比率≤6.6%或淋巴结转移数≤3的患者总生存和无进展生存均显著改善(p<0.05)。
- 淋巴结检出数未显示预后意义。
- AIC分析提示淋巴结转移数是优于淋巴结检出数和淋巴结比率的预后指标。
关键数值与推荐
- 淋巴结比率预后阈值为6.6%,淋巴结转移数预后阈值为3,淋巴结检出数预后阈值为22。
- 淋巴结比率≤6.6%或淋巴结转移数≤3的患者总生存和无进展生存显著改善(p<0.05)。
临床怎么用
- 作者认为将淋巴结比率或淋巴结转移数纳入TNM分类可能提高预后价值。
- 作者建议未来N分期应考虑纳入淋巴结转移数。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to assess the prognostic significance of lymph node yield (LNY), lymph node ratio (LNR), and the number of lymph node metastases (LNMs) in patients affected by oral squamous cell carcinoma (OSCC). METHODS: The study included patients who underwent surgical treatment for primary OSCC. Receiver operating characteristic curves were generated to determine the optimal threshold values. Kaplan-Meier curves were employed, along with the log-rank test, for the analysis of survival. To compare the performance in terms of model fit, we computed Akaike's information criterion (AIC). RESULTS: This study enrolled 429 patients. Prognostic thresholds were determined at 22 for LNY, 6.6% for LNR, and 3 for the number of LNMs. The log-rank test revealed a significant improvement in both overall survival and progression-free survival for patients with a LNR of ≤6.6% or a number of LNMs of ≤3 (p < 0.05). Interestingly, LNY did not demonstrate prognostic significance. The AIC analyses indicated that the number of LNMs is a superior prognostic indicator compared to LNY and LNR. CONCLUSIONS: Incorporating LNR or the number of LNMs into the TNM classification has the potential to improve the prognostic value, as in other types of cancers. Particularly, the inclusion of the number of LNMs should be contemplated for future N staging.
引用
- Struckmeier AK, Buchbender M, Lutz R, et al. Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma. Head Neck. 2024. PMID: 38501325. doi:10.1002/hed.27748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。